title: Efficacy of thalidomide-based therapy following lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma.
authors.forename: Vishal
authors.initials: V
authors.lastname: Kukreti
authors.forename: Esther
authors.initials: E
authors.lastname: Masih-Khan
authors.forename: Trieu
authors.initials: T
authors.lastname: Young
authors.forename: Chia-Min
authors.initials: CM
authors.lastname: Chu
authors.forename: Haiyun
authors.initials: H
authors.lastname: Jiang
authors.forename: Suzanne
authors.initials: S
authors.lastname: Trudel
authors.forename: Christine
authors.initials: C
authors.lastname: Chen
authors.forename: Victor
authors.initials: V
authors.lastname: Jimenez-Zepeda
authors.forename: Donna E
authors.initials: DE
authors.lastname: Reece
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003907:Dexamethasone / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology; D012008:Recurrence; D012189:Retrospective Studies; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives; D016896:Treatment Outcome
chemical_list: D013792:Thalidomide; D003907:Dexamethasone; D000077269:Lenalidomide